-
741
Natural Products for Cancer Therapy: A Review of Their Mechanism of Actions and Toxicity in the Past Decade
Published 2022-01-01“…One of the major challenges in cancer research is the toxicity exerted by investigational agents towards the host. …”
Get full text
Article -
742
-
743
-
744
Standardization of Syndrome Differentiation Defined by Traditional Chinese Medicine in Operative Breast Cancer: A Modified Delphi Study
Published 2015-01-01“…We carried out two rounds of investigation between March and October 2013 and organized 20 experts who focused on TCM or integrative medicine in breast cancer research. Experts’ judgments were collected via posted questionnaires or e-mail. …”
Get full text
Article -
745
On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach
Published 2017-01-01Get full text
Article -
746
-
747
Artificial intelligence across oncology specialties: current applications and emerging tools
Published 2024-07-01Get full text
Article -
748
Novel research model for in vitro immunotherapy: co-culturing tumor organoids with peripheral blood mononuclear cells
Published 2024-12-01“…Abstract Tumor organoids have emerged as powerful tools for in vitro cancer research due to their ability to retain the structural and genetic characteristics of tumors. …”
Get full text
Article -
749
Comparison of BRCA1 Gene Expression and CA15-3 Tumor Marker Level in Different Stages of Breast Cancer
Published 2024-01-01Get full text
Article -
750
Cellular Senescence as a Target in Cancer Control
Published 2011-01-01“…Given that the ultimate goal of cancer research is to find the definitive cure for as many tumor types as possible, exploration of cellular senescence to drive towards antitumor therapies may decisively influence the outcome of new drugs. …”
Get full text
Article -
751
Protocol for a patient-derived preclinical platform to model tumor-immune interactions and evaluate therapeutic efficacy
Published 2025-03-01“…By preserving tumor architecture and heterogeneity, this model is applicable for evaluating tumor characteristics, immune interactions, and treatment efficacy in translational cancer research. : Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.…”
Get full text
Article -
752
Editorial: Specific targeting of MHC antigens for T-cells and immune cells in human disease
Published 2025-01-01Get full text
Article -
753
CXCL14 in prostate cancer: complex interactions in the tumor microenvironment and future prospects
Published 2025-01-01“…Such phenomena have also been observed in prostate cancer research. Despite a foundational understanding of CXCL14 in prostate cancer, there remains a lack of comprehensive reviews summarizing the specific roles of this chemokine and systematically analyzing the reasons behind its complex effects. …”
Get full text
Article -
754
CAR-T cell therapy in developing countries: how long should we wait?
Published 2024-12-01Get full text
Article -
755
-
756
Anal Incontinence after Anterior Rectum Resection in Cancer Patients
Published 2020-04-01“…The study was carried out at the Rostov Cancer Research Institute. All patients underwent R0 anterior rectum resection with the total mesorectumectomy and the formation of a preventive ileostomy. …”
Get full text
Article -
757
The TNF Receptors p55 and p75 Mediate Chemotaxis of PMN Induced by TNFα and a TNFα 36–62 Peptide
Published 1994-01-01Get full text
Article -
758
Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML
Published 2017-01-01Get full text
Article -
759
-
760
Treatment Choices for Tenosynovial Giant Cell Tumor: Surgery or Observation?
Published 2025-01-01Get full text
Article